| 2935.00.10 | 00 | 2-Amino-N-ethylbenzenesulfonanilide; 5-Amino- α, α, α-trifluorotoluene-2,4-disulfonamide; Benzenesulfonamide; Benzenesulfonyl hydrazide; 2-Chloro-4-amino-5-hydroxybenzenesulfonamide; 2,5-Dimethoxysulfanilanilide; and Metanilamide | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4¡é/kg + 41% |
| 2935.00.13 | 00 | (5-[2-Chloro-4-(trifluoromethyl)phenoxy]-¡é/(methylsulfonyl)-2-nitrobenzamide) (Fomesafen); N-(2,6-Dichloro-3-methylphenyl)-5-amino-1,3,4- triazole-2-sulfonamide; 2,4-Dichloro-5-sulfamoylbenzoic acid; N-Ethyl-o-toluenesulfonamide; N-Ethyl-p-toluenesulfonamide; 7-(Hexadecylsulfonylamino)-1H-indole; Methyl 5-{[(4,6-dimethoxy-2-pyrimidinyl)amino]- carbonylaminosulfonyl}-3-chloro-1-methyl-1H- pyrazole-4-carboxylate (Halosulfuron methyl); and Mixtures of ortho- and para-toluene sulfonamides | kg | Free | | 15.4¡é/kg + 57.5% |
| 2935.00.30 | 00 | Sulfamethazine | kg | Free | | 15.4¡é/kg + 80% |
| 2935.00.32 | 00 | Acetylsulfisoxazole; Sulfacetamide, sodium; and Sulfamethazine, sodium | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4¡é/kg + 96% |
| 2935.00.42 | 00 | Salicylazosulfapyridine (Sulfasalazine); Sulfadiazine; Sulfaguanidine; Sulfamerizine; and Sulfapyridine | kg | Free | | 15.4¡é/kg + 128.5% |
| 2939.61.00 | 00 | Ergometrine and its salts | kg | Free | | 25% |
| 2939.91.00 | 00 | Cocaine, ecgonine, levometamfetamine, metamfetamine (INN), metamfetamine racemate; salts, esters and other derivatives thereof | kg | Free | | 25% |
| 2942.00.03 | 00 | [2,2'-Thiobis(4-(1,1,3,3-tetramethyl-n-butyl)- phenolato)(2,1)]-O,O',S-(1-butanamine), nickel II | kg | Free | | 15.4¡é/kg + 46.5% |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3002.10.01 | | Antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes | | Free | | Free |
| 3002.20.00 | 00 | Vaccines for human medicine | kg | Free | | Free |
| 3002.30.00 | 00 | Vaccines for veterinary medicine | kg | Free | | Free |
| 3002.90.10 | 00 | Ferments | kg | Free | | 25% |
| 3003 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale: | | | | |
| 3004 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: | | | | |
| 3004.40.00 | 10 | Cardiovascular medicaments | kg | | | |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.50 | | Other medicaments containing vitamins or other products of heading 2936: | | | | |
| 3004.90.91 | 05 | Anti-infective medicaments: | | | | |
| 3004.90.91 | 15 | Antineoplastic and immunosuppressive medicaments | kg | | | |
| 3004.90.91 | 20 | Cardiovascular medicaments | kg | | | |
| 3004.90.91 | 22 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.90.91 | 22 | Tolmetin | kg | | | |
| 3004.90.91 | 24 | Tolmetin sodium dihydrate | kg | | | |
